Stay updated on Mirikizumab Maintenance Study in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Mirikizumab Maintenance Study in Ulcerative Colitis Clinical Trial page.

Latest updates to the Mirikizumab Maintenance Study in Ulcerative Colitis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedFooter updates include adding 'Revision: v3.3.3' and removing references to 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedAdded Revision: v3.3.2 to the Record History and removed Revision: v3.2.0.SummaryDifference0.0%

- Check48 days agoChange DetectedThe government funding lapse banner, which warned that information on the site may not be up to date and that agency operations could be affected, has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check63 days agoChange DetectedThe screenshots show the Record History page with multiple version entries and status updates (e.g., Study Status, Contacts/Locations, Recruitment Status). No substantive changes to the core study information are evident in the visible portions.SummaryDifference0.0%

- Check77 days agoChange DetectedAdds a new date and a new study status entry; removes an older date. Overall, updates time-related details with minimal impact on core content.SummaryDifference0.6%

- Check91 days agoChange DetectedUpgrade notice added and version bumped from v3.1.0 to v3.2.0; a government-funding-related operational notice is now displayed.SummaryDifference7%

Stay in the know with updates to Mirikizumab Maintenance Study in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mirikizumab Maintenance Study in Ulcerative Colitis Clinical Trial page.